Manager TitleAgeSince
Chief Executive Officer 49 30/05/2025
Director of Finance/CFO 61 30/05/2025
Sales & Marketing 53 31/12/2023
Director TitleAgeSince
Director/Board Member 62 31/12/2019
Chairman 42 31/05/2025
Director/Board Member 75 31/05/2025
Change 5-day change 1-year change 3-year change Capi.($)
-35.15%-30.97% - - 717K
+3.49%+1.36%-29.04%-11.02% 166B
+5.04%+2.73%-5.88%-4.53% 106B
+2.80%+3.63%+0.09%+55.31% 57.69B
+1.33%+1.39%+53.16%+49.84% 53.78B
+3.39%+1.39%-10.26%-39.65% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-43.91% 27.49B
+0.20%+4.24%+64.56%-3.33% 25.84B
+2.78%+1.17%-8.15%-0.43% 21.27B
Average -0.91%+4.67%+6.30%+0.29% 59.87B
Weighted average by Cap. +3.31%+3.80%-3.84%+1.05%
Logo ProstaLund AB
ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.
Employees
6
  1. Stock Market
  2. Stocks
  3. PLUN Stock